China’s Drastic Reduction in Cancer Drug Price

It is positive news for the public that China is observing faster price cuts on oncology drugs. This major incident has taken place due to turmoil over a movie which revealed smugglers who were sneaking cheaper generic drugs into the country. This resulted in big pharma therapeutic drugs being targeted for cuts.
The newly formed health insurance administration in China intend to deepen discounts on cancer drugs which were already on its National Reimbursement Drug List (NRDL) based on public bidding and procurement based on cancer therapies. In the meantime, officials will start enlisting negotiations for treatments which were not included on the coverage list.
A novel dimension on cancer costs was declared in a government press conference, right before the removal of import tariffs and decreased import value-added tax to 3% on all commonly available cancer therapies. The Chinese government hopes that the drug companies will keep this decision in mind when fixing prices on therapies.
Due to China’s streamlined drug review process, novel effective cancer therapies such as Bristol-Myers Squibb’s Opdivo and AstraZeneca’s Tagrisso are entering the market with full swing. This entry resulted in the government being forced to negotiate prices to swiftly make these cancer therapies accessible to all patients.
But Chinese healthcare reform expert Jiemian, Zhu Hengpeng, who heads the Center for Public Policy Research at the Chinese Academy of Social Sciences, advised that low priced drugs could have long-term negative effects on innovation, especially for domestic drugmakers.  
Under this Chinese insurance scheme, hospitals would be given a specific amount to treat each patient for a particular disease. Hence doctors would have less incentive in order to use high-cost drugs.
The post China’s Drastic Reduction in Cancer Drug Price appeared first on Drugdu.com
from Drugdu  https://goo.gl/QgQoHk

评论

发表评论

此博客中的热门博文

The future of lung function tests for COPD

With the global increase of  lung diseases  such as asthma, severe bronchitis and emphysema,  lung function tests  are becoming a bigger concern for many people. Spirometry  (measuring lung function) is the most well know  pulmonary function test  and vital to diagnose  COPD . Some of the diseases which can be detected are: 1. Chronic obstructive pulmonary disease (COPD) – main term used to describe lung diseases such as asthma, emphysema, chronic bronchitis etc. 2. Asthma – common and long-term lung disease characterised by coughing, shortness of breath or wheezing. 3. Chronic bronchitis – bronchial tubes become inflamed and produce an excessive amount of mucus. 4. Emphysema – long-term progressive disease where alveoli in the lungs become inflamed causing shortness of breath. 5. Cystic fibrosis – genetic lung disease characterised by frequent lung infections and coughing up mucus as a result of this. 6. Pulmonary fibrosis - interstitial lungdiseases resulting in the
阅读全文

Consumption of Crickets Support the Growth of Beneficial Gut Bacteria

图片
Valerie Stull, a doctoral graduate from the University of Wisconsin-Madison Nelson Institute for Environmental Studies published the results of her study on the benefits of consuming crickets on gut bacteria in the journal  Scientific Reports.  It is not only safe at high doses but may also reduce inflammation in the body Valerie Stull said that she was 12 when she ate her first insect. She said,  “I was on a trip with my parents in Central America and we were served fried ants; I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food — and it was good!” Stull further added,  “There is a lot of interest right now in edible insects; It’s gaining traction in Europe and in the U.S. as a sustainable, environmentally friendly protein source compared to traditional livestock.” Tiffany Weir, the co-corresponding author and a professor of food science and human nutrition at Colorado State University said,  “Thi
阅读全文

Press Conference for Ddu Credit Verification Launch

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to
阅读全文